gracetx.com (GRCE) - Earnings per share increase in current year

Official company branding of gracetx.com (GRCE)

The stability of Grace Therapeutics, Inc. (GRCE) is validated by its scientific authority and research precision, which bolsters the year-over-year growth rate of earnings per share. The business relies on long-term demand for the therapy of rare brain pathologies, although current costs for discovering new molecules are increasing unit costs. The -44.10 indicator expresses the state of the metric, capturing the company's final yield dynamics.

Grace Tx (GRCE) - Earnings growth in current year from 10/29/2024 to 11/17/2026

Analytical breakdowns and data insights for company Grace Tx (GRCE)

- stock value and consensus price forecast:
Fundamental valuation:Grace Therapeutics, Inc.
Signature product of Grace Therapeutics Inc

This indicator measures the year-over-year dynamics of earnings per share, assessing deviations of current values from the historical average. Tracking annual EPS growth allows for the identification of abnormal earnings spikes or sustainable capitalization trends. For Grace Therapeutics, Inc. (GRCE), this metric reflects the financial efficiency of developing drugs against brain pathologies. The scientific community's high level of confidence in the company's clinical trials translates into the stability of this indicator. A positive trajectory confirms the viability of the high-tech business model.

Main competitors

Earnings per share growth rate in current year Biogen Idec (BIIB)|NBIX (neurocrine.com) - Earnings growth in current year|Earnings per share growth rate in current year regencellbioscience.com RGC|Net earnings per share growth this year AXSM (Axsome Therapeutics, Inc.)|ACAD (ACADIA Pharma) - Earnings per share increase in current year|Earnings growth in current year XENE (Xenon Pharmaceuticals Inc)|Net earnings per one share growth for the current year VKTX (Viking Pharma)|SUPN: Net earnings per share growth this year|Earnings per share increase in current year CPRX (catalystpharma.com)|DNLI: Earnings growth in current year|HRMY - Expected net earnings per share growth this year|Net earnings per share growth this year BHVN|AMLX: Earnings per share increase in current year|Earnings per share growth in current year Trevi Pharma (TRVI)|Expected net earnings per share growth this year praxismedicines.com|Earnings per share growth in current year Anavex AVXL|Expected net earnings per share growth this year CeriBell (CBLL)|PRTA - Earnings per share growth in current year|ALEC: Earnings per share growth in current year|Annexon (ANNX) - Earnings per share growth in current year|OMER: Net earnings per one share growth for the current year|NGNE (neurogene.com) - Earnings growth in current year|Earnings growth in current year AC Immune S.A.|Net earnings per share growth this year VYGR (Voyager Therapeutics, Inc.)|Net earnings per one share growth for the current year NMRA|Earnings per share growth in current year scilexholding.com SCLX|TVGN: Earnings per share growth this year|alphacognition.com - Earnings growth in current year|Cognition Therapeutics - Net earnings per one share growth for the current year|IKT: Earnings growth in current year|Net earnings per share growth this year Cassava Sciences, Inc.|ASRT (assertiotx.com) - Earnings growth in current year|Net earnings per share growth this year Coya Therapeutics (COYA)|Net earnings per share growth this year VTGN (Vistagen)|Expected net earnings per share growth this year Ovid Therapeutics Inc|Earnings growth in current year ABOS (Acumen Pharmaceuticals Inc.)|CRVO - Net earnings per share growth this year|Alterity Therapeutics Limited - Earnings growth in current year|Earnings per share growth rate in current year Clene Inc|PEPG: Earnings growth in current year|Net earnings per share growth this year jupiterneurosciences.com|RLMD (relmada.com) - Earnings growth in current year|Earnings growth in current year Annovis Bio Corporation|Earnings growth in current year AIFF|Net earnings per one share growth for the current year KLTO|Earnings per share growth in current year neurosense-tx.com NRSN|Reviva Pharmaceuticals Holdings (RVPH) - Earnings per share growth rate in current year|MetaVia Inc. - Earnings growth in current year|Expected net earnings per share growth this year NeurAxis Inc NRXS|HSDT (Helius Medical Technologies Inc.) - Net earnings per share growth this year|Passage Bio Inc. (PASG) - Earnings growth in current year|Earnings per share growth in current year Neuphoria|Net earnings per share growth this year Minerva Neurosciences, Inc. (NERV)|Earnings per share growth in current year Athira (ATHA)|Addex Therapeutics - Earnings per share growth this year|Earnings per share growth in current year Alzamend Neuro, Inc. ALZN|Cyclerion (CYCN) - Earnings per share growth rate in current year|PTIX - Earnings per share growth in current year|Expected net earnings per share growth this year Pasithea Therapeutics Corp KTTA|Cortigent, Inc. (CRGT) - Earnings per share growth in current year|Avenue Therapeutics - Earnings per share increase in current year|BCLI (brainstorm-cell.com) - Earnings growth in current year|CARA: Earnings per share increase in current year|Earnings per share growth in current year Chromocell Therapeutics Corp (CHRO)|ELYM (Eliem Therapeutics Inc.) - Earnings per share increase in current year|Earnings growth in current year ITCI (Intra-Cellular Therapies Inc.)|Net earnings per share change in current year Longboard Pharma|MRNS - Earnings per share growth in current year|NKGen Biotech, Inc. (NKGN) - Net earnings per share growth this year|NRBO (NeuroBo Pharmaceuticals, Inc.) - Net earnings per share growth this year|Sage Therapeutics - Earnings per share increase in current year|Earnings per share growth in current year Synaptogenix, Inc.|TRVN: Earnings per share increase in current year|Earnings growth in current year VIGL|Net earnings per share growth this year Anew Medical, Inc. WENA|Earnings per share growth in current year Cerevel Therapeutics CERE